2021 annual financial data
Cytosorbents 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -34.92%.
Operating income was -22,744,745 USD and net income was -24,558,648 USD.
Operating cash flow was -14,005,599 USD.
Get free Cytosorbents email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 40,108,567 USD
- Operating income
- -22,744,745 USD
- Net income
- -24,558,648 USD
- Operating cash flow
- -14,005,599 USD